Univariate Analysis of Patient and Provider Variables Associated With Having a PrEP Discussion During a Primary Care Visit
| PrEP Conversations | PrEP Conversations | ||
|---|---|---|---|
| With Variable | With Variable | ||
| Variable | Present, % | Absent, % | P Value |
| Documentation of STI history (positive or negative) | 57.7 | 21.4 | <0.001 |
| Documentation of condom use (consistent or inconsistent) | 50.0 | 17.8 | <0.001 |
| HIV testing | 47.0 | 0.0 | <0.001 |
| STI testing (other than HIV) | 42.0 | 7.0 | <0.001 |
| Saw MSM specialist | 47.2 | 21.5 | 0.005 |
| Sexually active | 31.5 | 0.0 | 0.077 |
HIV, human immunodeficiency virus; MSM, men who have sex with men; PrEP, pre-exposure prophylaxis (emtricitabine/tenofovir disoproxil fumarate [Truvada]); STI, sexually transmitted infection.